中文English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R

留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

关注药物性肝衰竭

苏海滨 王慧芬

引用本文:
Citation:

关注药物性肝衰竭

详细信息
  • 中图分类号: R575.3

Clinical significance of drug-induced liver failure

  • 摘要:

    <正>随着经济发展、健康保健意识增强以及新药的不断问世,药物性肝病(drug-induced liver damage,DILD)及药物性肝衰竭(drug-induced liver failure,DILF)的发病率也在不断增加[1-2]。DILF是指在药物使用过程中,药物或其活性代谢产物引起的肝细胞大量坏死或肝功能急剧严重损害,肝脏合成、解毒、排泄和生物转化等功能发生严重障碍或失代偿的严重疾病。由于肝衰竭的病理生理过程极为复杂,对严重的临床症候群缺乏特异性治疗手段,因此病死率极高。

     

  • [1]Aithal GP, Watkins PB, Andrade RJ, et al.Case definition and phenotype standardization in drag-induced liver injury[J].Clin Pharmacol Ther, 2011, 89 (6) :806-815.
    [2]Au JS, Navarro VJ, Rossi S.Drug-induced liver injury-its pathophysiology and evolving diagnotic tools[J].Aliment Pharmacol Ther, 2011, 34 (1) :11-20.
    [3]Lee WM.Drug-induced hepatotoxicity[J].N Engl J Med, 2003, 349 (5) :474-485.
    [4]Lee WM.Acetaminophen and the U.S.Acute Liver Failure Study Group:lowering the risks of hepatic failure[J].Hepa-tology, 2004, 40 (1) :6-9.
    [5]Graham DJ, Green L, Senior JR, et al.Troglitazone-induced liver failure:a case study[J].Am J Med, 2003, 114 (4) :299-306.
    [6]McKenzie R, Fried MW, Sallie R, et al.Hepatic failure and lactic acidosis due to fialuridine (FIAU) , an investigational nucleoside analogue for chronic hepatitis B[J].N Engl J Med, 1995, 333 (17) :1099-1105.
    [7]Lee WM, Larson AM, Stravitz RT.AASLD position paper:the management of acute liver failure:Update2011[J].Hepatology, 2011, 41 (5) :1-22.
    [8]刘晓燕, 胡瑾华, 王慧芬, 等, 1977例急性、亚急性、慢加急性肝衰竭患者的病因与转归分析[J].中华肝脏病杂志, 2008, 16 (10) :772-775.
    [9]滕光菊, 张伟, 孙颖, 等.141例药物性肝衰竭临床特征及预后分析[J].传染病信息, 2011, 24 (5) :286-289.
    [10]Russmann S, Jetter A, Kullak-Ublick GA.Pharmacogenet-ics of drug-induced liver injury[J].Hepatology, 2010, 52 (2) :748-761.
    [11]Kaplowitz N.Idiosyncratic drug hepatotoxidty[J].Nat Rev Drug Discov, 2005, 4 (6) :489-499.
    [12]陈成伟, 缪晓辉.细胞色素P450遗传多态性与药物性肝病[J].肝脏, 2002, 7 (4) :263-264.
    [13]Michael P, Cynthia JU.Mechanisms of drug-induced liver injury[J].AAPS J, 2006, 8 (1) :48-54.
    [14]RussmannS, Kullak-Ublick GA, Grattagliao I.Current con-cepts of mechanisms inDrug-induced hepatotoxicity[J].Curr Med Chen, 2009, 16 (23) :3041-3053.
    [15]Danan G, Benichou C.Causality assessment of adverse re-actions to drugs-I.A novel method based on the conclu-sions of international consensus meetings:application to drug-induced liver injuries[J].J Clin Epidemiol, 1993, 46 (11) :1323-1330.
    [16]Maria VA, Victorino RM.Development and validation of a clini-cal scale for the diagnosis of drug-induced hepatitis[J].Hepa-tology, 1997, 26 (3) :664-669.
    [17]许彪, 何卫平, 张爱民, 等.两种国际诊断标准对230例药物性肝损害诊断的分析比较[J].中华肝脏病杂志, 2007, 15 (12) :926-929.
  • 加载中
计量
  • 文章访问数:  2973
  • HTML全文浏览量:  9
  • PDF下载量:  788
  • 被引次数: 0
出版历程
  • 出版日期:  2012-10-20
  • 分享
  • 用微信扫码二维码

    分享至好友和朋友圈

目录

    /

    返回文章
    返回